Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2017 (2017), Article ID 1421204, 3 pages
https://doi.org/10.1155/2017/1421204
Case Report

A Rare Case of Recurrent Mucoepidermoid Carcinoma of the Nasal Vestibule

1School of Medicine, Department of Otorhinolaryngology and Head and Neck Surgery, Sisters of Mercy University Hospital Center, University of Zagreb, Zagreb, Croatia
2School of Medicine, Department of Otorhinolaryngology and Head and Neck Surgery, University of Mostar, Mostar, Bosnia and Herzegovina
3School of Medicine, Croatian Health Insurance Fund, Zagreb, Croatia
4School of Dental Medicine, Dental Clinic Apolonia, Zagreb, Croatia

Correspondence should be addressed to Mirjana Kostić; rh.ozzh@citsok.anajrim

Received 18 April 2017; Accepted 1 August 2017; Published 13 September 2017

Academic Editor: Constantine Gennatas

Copyright © 2017 Vladimir Bedeković et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

We report a rare case of a large recurrent mucoepidermoid carcinoma (RMEC) in an 81-year-old female smoker, which has originated in the right nasal vestibule. The recurrent tumour was inadequately treated for 6 years. It was a slow-growing tumour for 3 years and then began to enlarge at a higher pace. In the next three years it has covered a large part of the face. The patient had refused any medical treatment. The tumour caused breathing and swallowing difficulties. Because of the profuse bleeding from the tumour, the patient underwent emergency surgery. Surgical treatment consisted of rhinectomy and resection of the central upper lip and part of the right cheek. The facial defect was reconstructed immediately. Recovery from surgery was fast with no complications. Postoperative Multislice Computed Tomography scan showed no metastases so the patient did not receive any chemotherapy or radiotherapy. During a 2.5 years’ follow-up period there was no recurrence of the disease.